Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cells

Immune checkpoint inhibitors activate T cells to reject tumors. Unique tumor mutations are key T-cell targets, but a comprehensive understanding of the nature of a successful antitumor T-cell response is lacking. To investigate the T-cell receptor (TCR) repertoire associated with treatment success v...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Immunol Res
Asıl Yazarlar: Rudqvist, Nils-Petter, Pilones, Karsten A., Lhuillier, Claire, Wennerberg, Erik, Sidhom, John-William, Emerson, Ryan O., Robins, Harlan S., Schneck, Jonathan, Formenti, Silvia C., Demaria, Sandra
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020019/
https://ncbi.nlm.nih.gov/pubmed/29180535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0134
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller